A.I. BURNASYAN FMBC CLINICAL BULLETIN

ISSN 2782-6430 (print)

State Research Center −Burnasyan Federal Medical Biophysical
Center of Federal Medical Biological Agency

The journal is published in Russian.
Format – A4.
The periodicity of the journal is 4 times a year.

Issue №2 2025 год

more

A.I. Burnasyan  FMBC clinical bulletin. 2024 № 1

I.N. Posokhov

Pregnancy, Kidneys, Hypertension

International Office, State Research Center – Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Moscow, Russiа

Contact person: Posokhov Igor Nicolaevich: igor@posohov.ru

Abstract
Preeclampsia, often presenting as new-onset hypertension and proteinuria in the third trimester of pregnancy, can rapidly progress to serious complications and therefore presents a unique challenge, simultaneously affecting both mother and fetus, sometimes putting their well-being at odds with each other. This condition may require fairly high competencies not only from obstetricians-gynecologists, but also from doctors of other specialties, including internists and general practitioners, cardiologists, nephrologists, laboratory and functional diagnostics doctors. This literature review was prepared with the aim of summarizing and briefly presenting modern ideas about theoretical and practical issues about the relationship between pregnancy, kidney function, and blood pressure that are important for these specialists.

Keywords: arterial hypertension, blood pressure measurements, eclampsia, glomerular endotheliosis, HELLP syndrome, pregnancy, podocytopathy, preeclampsia, posterior reversible encephalopathy syndrome, proteinuria, prediction of preeclampsia, soluble fms-like tyrosine kinase-1, thrombotic microangiopathy

For citation: Posohov IN. Pregnancy, Kidneys, Hypertension. A.I. Burnasyan Federal Medical Biophysical Center Clinical Bulletin. 2024.1:22-35. (In Russian) DOI: 10.33266/2782-6430-2024-1-22-35

 

REFERENCES

  1. WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. Geneva, World Health Organization, 2011. URL: https://www.ncbi.nlm.nih.gov/books/NBK140561/.
  2. Fishel Bartal M., Sibai B.M. Eclampsia in the 21st Century. Am. J. Obstet. Gynecol. 2022;226;2S:S1237-S1253. doi: 10.1016/j.ajog.2020.09.037.
  3. Yalçınkaya F., Özçakar Z.B. Management of Antenatal Hydronephrosis. Pediatr Nephrol. 2020;35;12:2231-2239. doi: 10.1007/s00467-019-04420-6.
  4. Georgescu T. The Role of Maternal Hormones in Regulating Autonomic Functions During Pregnancy. J. Neuroendocrinol. 2023;35;12:e13348. doi: 10.1111/jne.13348.
  5. Cheung K.L., Lafayette R.A. Renal Physiology of Pregnancy. Adv Chronic Kidney Dis. 2013;20;3:209-214. doi: 10.1053/j.ackd.2013.01.012.
  6. Hu J., Xu W., Yang H., Mu L. Uric Acid Participating in Female Reproductive Disorders: a Review. Reprod Biol. Endocrinol. 2021;19;1:65. doi: 10.1186/s12958-021-00748-7.
  7. Erman A., Neri A., Sharoni R., Rabinov M., Kaplan B., Rosenfeld J.B., Boner G. Enhanced Urinary Albumin Excretion after 35 Weeks of Gestation and During Labour in Normal Pregnancy. Scand. J. Clin. Lab. Invest. 1992;52;5:409-413. doi: 10.3109/00365519209088376.
  8. Vázquez-Arredondo J.G., Vázquez-Rodríguez J.G. Plasma Colloid Osmotic Pressure in Preeclampsia. Review of the Mexican literature 1997-2018. Cir. Cir. 2021;89;4:547-552. doi: 10.24875/CIRU.19001263.
  9. Schrier R.W. Systemic Arterial Vasodilation, Vasopressin, and Vasopressinase in Pregnancy. J. Am. Soc. Nephrol. 2010;21;4:570-572. doi: 10.1681/ASN.2009060653.
  10. Morton A. Physiological Changes and Cardiovascular Investigations in Pregnancy. Heart Lung. Circ. 2021;30;1:e6-e15. doi: 10.1016/j.hlc.2020.10.001.
  11. Sanghavi M., Rutherford J.D. Cardiovascular Physiology of Pregnancy. Circulation. 2014;130;12:1003-1008. doi: 10.1161/CIRCULATIONAHA.114.009029.
  12. Gennari-Moser C., Khankin E.V., Schüller S., et al. Regulation of Placental Growth by Aldosterone and Cortisol. Endocrinology. 2011;152;1:263-271. doi: 10.1210/en.2010-0525.
  13. Gintoni I., Adamopoulou M., Yapijakis C. The Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications. In Vivo. 2021;35;1:95-103. doi: 10.21873/invivo.12236.
  14. American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy, Author. Hypertension in Pregnancy / Developed by the Task Force on Hypertension in Pregnancy. Washington, DC, 2013. 100 р. ISBN 978-1-934984-28-4
  15. Tabacco S., Ambrosii S., Polsinelli V., et al. Pre-Eclampsia: From Etiology and Molecular Mechanisms to Clinical Tools-A Review of the Literature. Curr. Issues Mol. Biol. 2023;45;8:6202-6215. doi: 10.3390/cimb45080391.
  16. Verlohren S., Brennecke S.P., Galindo A., et al. Clinical Interpretation and Implementation of the sFlt-1/PlGF Ratio in the Prediction, Diagnosis and Management of Preeclampsia. Pregnancy Hypertens. 2022;27:42-50. doi: 10.1016/j.preghy.2021.12.003.
  17. Lecarpentier E., Tsatsaris V. Angiogenic Balance (sFlt-1/PlGF) and Preeclampsia. Ann. Endocrinol (Paris). 2016;77;2:97-100. doi: 10.1016/j.ando.2016.04.007.
  18. Ives C.W., Sinkey R., Rajapreyar I., Tita A.T.N., Oparil S. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2020;76;14:1690-1702. doi: 10.1016/j.jacc.2020.08.014.
  19. Li S., Hu Y.W. Pathogenesis of Uteroplacental Acute Atherosis: An Update on Current Research. Am. J. Reprod. Immunol. 2021;85;6:e13397. doi: 10.1111/aji.13397.
  20. Rana S., Burke S.D., Karumanchi S.A. Imbalances in Circulating Angiogenic Factors in the Pathophysiology of Preeclampsia and Related Disorders. Am. J. Obstet. Gynecol. 2022;226;2S:S1019-S1034. doi: 10.1016/j.ajog.2020.10.022.
  21. Moghaddas Sani H., Zununi Vahed S., Ardalan M. Preeclampsia: A Close Look at Renal Dysfunction. Biomed Pharmacother. 2019;109:408-416. doi: 10.1016/j.biopha.2018.10.082.
  22. Panek-Laszczyńska K., Konieczny A., Milewska E., Dąbrowska K., Bąchor R., Witkiewicz W., Szewczuk Z. Podocyturia as an Early Diagnostic Marker of Preeclampsia: a Literature Review. Biomarkers. 2018;23;3:207-212. doi: 10.1080/1354750X.2017.1405283.
  23. Trimarchi H. Mechanisms of Podocyte Detachment, Podocyturia, and Risk of Progression of Glomerulopathies. Kidney Dis (Basel). 2020;6;5:324-329. doi: 10.1159/000507997.
  24. Sircar M., Thadhani R., Karumanchi S.A. Pathogenesis of Preeclampsia. Curr. Opin. Nephrol. Hypertens. 2015;24;2:131-138. doi: 10.1097/MNH.0000000000000105.
  25. Irani R.A., Xia Y. The Functional Role of the Renin-Angiotensin System in Pregnancy and Preeclampsia. Placenta. 2008;29;9:763-771. doi: 10.1016/j.placenta.2008.06.011.
  26. Civieri G., Iop L., Tona F. Antibodies Against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies. Int. J. Mol. Sci. 2022;23;2:927. doi: 10.3390/ijms23020927.
  27. Tomimatsu T., Mimura K., Endo M., Kumasawa K., Kimura T. Pathophysiology of Preeclampsia: an Angiogenic Imbalance and Long-Lasting Systemic Vascular Dysfunction. Hypertens Res. 2017;40;4:305-310. doi: 10.1038/hr.2016.152.
  28. Gyselaers W. Hemodynamic Pathways of Gestational Hypertension and Preeclampsia. Am. J. Obstet. Gynecol. 2022;226;2S:S988-S1005. doi: 10.1016/j.ajog.2021.11.022.
  29. Magee L.A., Brown M.A., Hall D.R., et al. The 2021 International Society for the Study of Hypertension in Pregnancy Classification, Diagnosis & Management Recommendations for International Practice. Pregnancy Hypertens. 2022;27:148-169. doi: 10.1016/j.preghy.2021.09.008.
  30. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135;6:e237-e260. doi: 10.1097/AOG.0000000000003891.
  31. Magee L.A., Smith G.N., Bloch C., et al. Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management. J. Obstet. Gynaecol. Can. 2022;44;5:547-571.e1. doi: 10.1016/j.jogc.2022.03.002.
  32. Преэклампсия. Эклампсия. Отеки, протеинурия и гипертензивные расстройства во время беременности, в родах и послеродовом периоде: Клинические рекомендации. 2021. [Preeclampsia. Eclampsia. Edema, Proteinuria and Hypertensive Disorders During Pregnancy, Childbirth and the Postpartum Period. Clinical Guidelines. 2021 (In Russ.)].
  33. Mancia G., Kreutz R., Brunström M., et al. 2023 ESH Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J. Hypertens. 2023;41;12:1874-2071. doi: 10.1097/HJH.0000000000003480.
  34. Артериальная гипертензия у взрослых: Клинические рекомендации. 2022. [Arterial Hypertension in Adults. Clinical Guidelines. 2022 (In Russ.)].
  35. Mayer-Pickel K., Nanda M., Gajic M., Cervar-Zivkovic M. Preeclampsia and the Antiphospholipid Syndrome. Biomedicines. 2023;11;8:2298. doi: 10.3390/biomedicines11082298.
  36. Gewirtz A.N., Gao V., Parauda S.C., Robbins M.S. Posterior Reversible Encephalopathy Syndrome. Curr. Pain. Headache Rep. 2021;25;3:19. doi: 10.1007/s11916-020-00932-1.
  37. Gardikioti A., Venou T.M., Gavriilaki E., Vetsiou E., Mavrikou I., Dinas K., Daniilidis A., Vlachaki E. Molecular Advances in Preeclampsia and HELLP Syndrome. Int. J. Mol. Sci. 2022;23;7:3851. doi: 10.3390/ijms23073851.
  38. Wallace K., Harris S., Addison A., Bean C. HELLP Syndrome: Pathophysiology and Current Therapies. Curr. Pharm. Biotechnol. 2018;19;10:816-826. doi: 10.2174/1389201019666180712115215.
  39. Parati G., Stergiou G.S., Bilo G., et al. Home Blood Pressure Monitoring: Methodology, Clinical Relevance and Practical Application: a 2021 Position Paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension. J. Hypertens. 2021;39;9:1742-1767. doi: 10.1097/HJH.0000000000002922.
  40. Validated Devices for Blood Pressure Measurement in Pregnancy / Preeclampsia. STRIDEBP: Joint Initiative of European Society of Hypertension, International Society of Hypertension and World Hypertension League. URL: https://www.stridebp.org/bp-monitors/37-pdfs/734-home?format=pdf&tmpl=component&box=pregnancy. (Available 12.12.2023).
  41. No Authors Listed. Comparison of the BPLab Sphygmomanometer for Ambulatory Blood Pressure Monitoring with Mercury Sphygmomanometry in Pregnant Women: Validation Study According to the British Hypertension Society Protocol [Retraction]. Vasc. Health. Risk. Manag. 2021;17:799-800. doi: 10.2147/VHRM.S352187.
  42. No Authors Listed. Validation of the BPLab 24-Hour Blood Pressure Monitoring System According to the European Standard BS EN 1060-4:2004 and British Hypertension Society Protocol [Retraction]. Med. Devices (Auckl). 2023;16:55-56. doi: 10.2147/MDER.S412296.
  43. Fishel Bartal M., Lindheimer M.D., Sibai B.M. Proteinuria During Pregnancy: Definition, Pathophysiology, Methodology, and Clinical Significance. Am. J. Obstet. Gynecol. 2022;226;2S:S819-S834. doi: 10.1016/j.ajog.2020.08.108.
  44. Gribble R.K., Fee S.C., Berg R.L. The Value of Routine Urine Dipstick Screening for Protein at Each Prenatal Visit. Am. J. Obstet. Gynecol. 1995;173;1:214-7. doi: 10.1016/0002-9378(95)90193-0.
  45. Yamada T., Kojima T., Akaishi R., Ishikawa S., Takeda M., Kawaguchi S., Nishida R., Morikawa M., Yamada T., Minakami H. Problems in Methods for the Detection of Significant Proteinuria in Pregnancy. J. Obstet. Gynaecol. Res. 2014;40;1:161-166. doi: 10.1111/jog.12148.
  46. Magee L.A., von Dadelszen P., Stones W., Mathai M. The FIGO Textbook of Pregnancy Hypertension: an Evidence-Based Guide to Monitoring, Prevention and Management. The Global Library of Women’s Medicine. 2016. 456 p. ISBN: 978-0-9927545-5-6
  47. Deshpande J.S., Sundrani D.P., Sahay A.S., Gupte S.A., Joshi S.R. Unravelling the Potential of Angiogenic Factors for the Early Prediction of Preeclampsia. Hypertens Res. 2021;44;7:756-769. doi: 10.1038/s41440-021-00647-9.
  48. Brookfield K.F., Mbata O. Magnesium Sulfate Use in Pregnancy for Preeclampsia Prophylaxis and Fetal Neuroprotection: Regimens in High-Income and Low/Middle-Income Countries. Obstet. Gynecol. Clin. North. Am. 2023;50;1:89-99. doi: 10.1016/j.ogc.2022.10.003.
  49. ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. Obstet. Gynecol. 2018;132;1:e44-e52. doi: 10.1097/AOG.0000000000002708.

 

Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors. 
Article received: 15.09.2023. Accepted for publication: 16.10.2023

© 2025 Scientific journal - "Clinical Bulletin of the FMBС im. A.I. Burnasyan"
Scroll to Top